Ipilimumab-dependent cell-mediated cytotoxicity of regulatory T cells ex vivo by nonclassical monocytes in melanoma patients
Emanuela Romano(Inserm), Daniel E. Speiser(University of Lausanne)
Cited by 581
Related Papers
Exhaustion of tumor-specific CD8+ T cells in metastases from melanoma patients
|Journal of Clinical Investigation|2011|820
Frequencies of circulating MDSC correlate with clinical outcome of melanoma patients treated with ipilimumab
|Cancer Immunology Immunotherapy|2013|560
CD4+ T cells in cancer
|Nature Cancer|2023|450
Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma
|Cancer Cell|2020|379
Site and Timing of First Relapse in Stage III Melanoma Patients: Implications for Follow-Up Guidelines
|Journal of Clinical Oncology|2010|253